Skip to content
Recall Observatory FDA recall evidence

Drug product

ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-0891-06), c) 5 grams (NDC 38779-0891-03), d) 25 grams (NDC 38779-0891-04), and e) 100 grams (NDC 38779-0891-09) Bottles, Packed by MEDISCA INC. PLATTSBURGH, NY 12901; Product Code 0891

D-0664-2017

April 03, 2017

Class II

Product summary

Firm
Medisca, Inc.
Event
Event 76873
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0664-2017

Official wording

Reason: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Code information: a) 124880/D,124880/O, 130940/J, 135312/E b) 124880/C 124880/F 124880/I 124880/N 130940/D 130940/I 135312/D 135312/I 136546/D 139489/B c) 124880/B, 124880/H, 124880/M, 130940/C, 130940/H, 135312/C, 135312/H, 136546/C d) 124880/A ,130940/B, 130940/G, 135312/B, 135312/G, 136546/B, 139489/A e) 124880/G, 124880/J, 124880/L,130940/A, 130940/F, 135312/A, 135312/F, 136546/A

Distribution pattern: Nationwide, Australia, Bahamas, Italy, Singapore, Thailand, United Kingdom

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations